Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Changes in Serum Levels of Fabp4 and Hscrp After Administration of Omega-3 Fatty Acids Separately or + Vitamin E in Patients With Coronary Artery Disease
Ebrahim Nematipour Ghasemabadi
Ebrahim Nematipour Ghasemabadi

Professor of Cardiology

Department Cardiology

School of Medicine

Tehran Heart Center

Tehran University of Medical Sciences

Related Documents
1. Omega-3 Fatty Acid Modifies Serum Hsp 70 and Hs-Crp in Patients With Cardiovascular Disease: Randomized Double‐Blind Placebo-Controlled Trial, Acta Medica Iranica (2018)
2. The Effect of Omega-3 Fatty Acids on Serum Apelin Levels in Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial, Reports of Biochemistry and Molecular Biology (2017)
3. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial, Archives of Iranian Medicine (2017)
4. Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial, American Journal of Men's Health (2017)
5. Omega-3 Fatty Acids/Vitamin E Behave Synergistically on Adiponectin Receptor-1 and Adiponectin Receptor-2 Gene Expressions in Peripheral Blood Mononuclear Cell of Coronary Artery Disease Patients, Current Topics in Nutraceutical Research (2015)
6. Effects of Administration of Omega-3 Fatty Acids With or Without Vitamin E Supplementation on Adiponectin Gene Expression in Pbmcs and Serum Adiponectin and Adipocyte Fatty Acid-Binding Protein Levels in Male Patients With Cad, Anadolu Kardiyoloji Dergisi (2015)
7. Various Effects of Omega 3 and Omega 3 Plus Vitamin E Supplementations on Serum Glucose Level and Insulin Resistance in Patients With Coronary Artery Disease, Iranian Journal of Public Health (2016)
8. The Effect of Omega-3 Supplementation on Serum Levels of Ykl-40, Bmp-4, and Ox-Ldl in Men With Coronary Artery Disease: A Randomized Double-Blind Placebo-Controlled Trial, Progress in Nutrition (2019)
All Documents
1. An Anomalous Right Coronary Artery Originating From the Left Anterior Descending Artery, a Case Report of Successful Percutaneous Coronary Intervention; Pakitusi Desinioji Vainikine Arterija, Prasidedanti Is Kairiosios Priekines Nusileidzianciosios Arterijos: Sekmingos Perkutanines Koronarines Intervencijos Atvejo Aprasymas, Acta Medica Lituanica (2025)
2. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
3. First Iranian Guidelines for the Diagnosis, Management, and Treatment of Hyperlipidemia in Adults, Journal of Research in Medical Sciences (2024)
4. Left Anterior Descending Coronary Artery-Left Circumflex Coronary Artery Bifurcation Angle and Severity of Coronary Artery Disease; Is There Any Correlation? a Cross-Sectional Study, Health Science Reports (2024)
5. Comparative Outcomes of Percutaneous Transvenous Mitral Commissurotomy Between Low and High Wilkins Score, Asian Cardiovascular and Thoracic Annals (2023)
6. Evaluation of the Causes of Door-To-Balloon Time Delays in Patients With St-Elevation Myocardial Infarction at Tehran Heart Center, Journal of Tehran University Heart Center (2023)
7. Priority Setting in Cardiovascular Research in Iran Using Standard Indigenous Methods, Journal of Research in Medical Sciences (2022)
8. Priority Setting in Cardiovascular Research in Iran Using Standard Indigenous Methods, Journal of Research in Medical Sciences (2022)
9. One-Month Clinical Outcomes of St-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention at a High-Volume Cardiac Tertiary Center: Routine Hours Versus Off-Hours, Critical Pathways in Cardiology (2020)
10. One-Year Outcome of Patients With Coronary Artery Ectasia Undergoing Percutaneous Coronary Intervention: Clinical Implications and Question Marks, Journal of Tehran University Heart Center (2020)
11. Cha2ds2-Vasc Score As an Independent Predictor of Suboptimal Reperfusion and Short-Term Mortality After Primary Pci in Patients With Acute St Segment Elevation Myocardial Infarction, Medicina (Lithuania) (2019)
12. Effect of Age on Procedural Success, Complications, and Clinical Outcome From a Large Angioplasty Registry, Critical Pathways in Cardiology (2019)
13. Interleukin-10 and Transforming Growth Factor Beta1 Gene Polymorphisms in Chronic Heart Failure, Acta Biomedica (2019)
14. Omega-3 Fatty Acids and Vitamin E Supplementation Can Affect Gene Expressions of Sirt1, Foxo1 and Ucp-2 in Coronary Artery Disease Patients, Obesity Medicine (2019)
15. Strategies to Reduce the Door-To-Device Time in St-Elevation Myocardial Infarction Patients, Journal of Tehran University Heart Center (2019)
16. The Effect of Omega-3 Supplementation on Serum Levels of Ykl-40, Bmp-4, and Ox-Ldl in Men With Coronary Artery Disease: A Randomized Double-Blind Placebo-Controlled Trial, Progress in Nutrition (2019)
17. The Effect of Omega-3 Supplementation on Serum Levels of Ykl-40, Bmp-4, and Ox-Ldl in Men With Coronary Artery Disease: A Randomized Double-Blind Placebo-Controlled Trial, Progress in Nutrition (2019)
18. Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With St-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (Pci) According to the 24/7 Primary Pci Service Registry in Iran: Protocol for a Cross-Sectional Study, JMIR Research Protocols (2019)
19. Comparing Serum Level of Vitamin D3 in Patients With Isolated Coronary Artery Ectasia and Normal Coronary Artery Individuals, Archives of Iranian Medicine (2018)
20. Comparison of Left Ventricular Ejection Fraction Measurements by Echocardiography and Contrast Ventriculography: A Study on a Large Hospitalized Population, Iranian Heart Journal (2018)
21. Correlates of the “No-Reflow” or “Slow-Flow” Phenomenon in Patients Undergoing Primary Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2018)
22. Interleukin-2 and Interferon-Gamma Single Nucleotide Polymorphisms in Iranian Patients With Chronic Heart Failure, Avicenna Journal of Medical Biotechnology (2018)
23. Omega-3 Fatty Acid Modifies Serum Hsp 70 and Hs-Crp in Patients With Cardiovascular Disease: Randomized Double‐Blind Placebo-Controlled Trial, Acta Medica Iranica (2018)
24. Predictors of Long-Term Major Adverse Cardiac Events Following Percutaneous Coronary Intervention in the Elderly, Archives of Iranian Medicine (2018)
25. Predictors of Major Adverse Cardiac Events Following Elective Stenting of Large Coronary Arteries, Indian Heart Journal (2018)
26. Tumor Necrosis Factor-Alpha and Interleukin-6 Gene Polymorphisms in Iranian Patients With Ischemic Heart Failure, Avicenna Journal of Medical Biotechnology (2018)
27. Effect of Omega-3 Polyunsaturated Fatty Acids Supplementation on Body Composition and Circulating Levels of Follistatin-Like 1 in Males With Coronary Artery Disease: A Randomized Double-Blind Clinical Trial, American Journal of Men's Health (2017)
28. Impact of Sex on Long-Term Clinical Outcomes After Percutaneous Coronary Intervention, Critical Pathways in Cardiology (2017)
29. Omega-3 Fatty Acid Could Increase One of Myokines in Male Patients With Coronary Artery Disease: A Randomized, Double-Blind, Placebo-Controlled Trial, Archives of Iranian Medicine (2017)
30. The Effect of Omega-3 Fatty Acids on Serum Apelin Levels in Cardiovascular Disease: A Randomized, Double-Blind, Placebo-Controlled Trial, Reports of Biochemistry and Molecular Biology (2017)
31. Association of Interleukin 1 Gene Cluster and Interleukin 1 Receptor Gene Polymorphisms With Ischemic Heart Failure, Bratislava Medical Journal (2016)
32. Beneficial Effects of Omega-3 and Vitamin E Coadministration on Gene Expression of Sirt1 and Pgc1α and Serum Antioxidant Enzymes in Patients With Coronary Artery Disease, Nutrition# Metabolism and Cardiovascular Diseases (2016)
33. Biodegradable-Polymer Biolimus-Eluting Stents Versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study, Texas Heart Institute Journal (2016)
34. Comparing Clinical Outcomes for a Twelve-Month Trial of Zotarolimus- and Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Data From the Thcric Registry, Therapeutic Advances in Cardiovascular Disease (2016)
35. Various Effects of Omega 3 and Omega 3 Plus Vitamin E Supplementations on Serum Glucose Level and Insulin Resistance in Patients With Coronary Artery Disease, Iranian Journal of Public Health (2016)
36. A Risk-Scoring Model to Predict One-Year Major Adverse Cardiac Events After Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)
37. Effects of Administration of Omega-3 Fatty Acids With or Without Vitamin E Supplementation on Adiponectin Gene Expression in Pbmcs and Serum Adiponectin and Adipocyte Fatty Acid-Binding Protein Levels in Male Patients With Cad, Anadolu Kardiyoloji Dergisi (2015)
38. Omega-3 Fatty Acids/Vitamin E Behave Synergistically on Adiponectin Receptor-1 and Adiponectin Receptor-2 Gene Expressions in Peripheral Blood Mononuclear Cell of Coronary Artery Disease Patients, Current Topics in Nutraceutical Research (2015)
39. Relationship Between Body Mass Index and Outcome of Elective Percutaneous Coronary Intervention, Journal of Tehran University Heart Center (2015)
40. The Impact of Cytochrome P450 2C19 Polymorphism on the Occurrence of One-Year In-Stent Restenosis in Patients Who Underwent Percutaneous Coronary Intervention: A Case-Match Study, Anadolu Kardiyoloji Dergisi (2015)
41. Ω-3 Fatty Acid Differentially Modulated Serum Levels of Igf1 and Igfbp3 in Men With Cvd: A Randomized, Double-Blind Placebo-Controlled Study, Nutrition (2015)